U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C19H21N3O8
Molecular Weight 419.3853
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FK-317

SMILES

COC1=CC(C=O)=CC2=C1[C@H](COC(N)=O)C3(OC(C)=O)ON2C[C@H]4[C@@H]3N4C(C)=O

InChI

InChIKey=BUZDGGFWWPZBIN-DHZLCAPXSA-N
InChI=1S/C19H21N3O8/c1-9(24)22-14-6-21-13-4-11(7-23)5-15(27-3)16(13)12(8-28-18(20)26)19(30-21,17(14)22)29-10(2)25/h4-5,7,12,14,17H,6,8H2,1-3H3,(H2,20,26)/t12-,14-,17-,19?,22?/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H21N3O8
Molecular Weight 419.3853
Charge 0
Count
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 3 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
1998
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:26:25 GMT 2025
Edited
by admin
on Mon Mar 31 18:26:25 GMT 2025
Record UNII
85J6JHT779
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FR-073317
Preferred Name English
FK-317
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID10858817
Created by admin on Mon Mar 31 18:26:25 GMT 2025 , Edited by admin on Mon Mar 31 18:26:25 GMT 2025
PRIMARY
PUBCHEM
121492536
Created by admin on Mon Mar 31 18:26:25 GMT 2025 , Edited by admin on Mon Mar 31 18:26:25 GMT 2025
PRIMARY
CAS
102409-92-7
Created by admin on Mon Mar 31 18:26:25 GMT 2025 , Edited by admin on Mon Mar 31 18:26:25 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
FDA UNII
85J6JHT779
Created by admin on Mon Mar 31 18:26:25 GMT 2025 , Edited by admin on Mon Mar 31 18:26:25 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY